Exchange: NASDAQ·Updated 01:37 PM EDT
ABSI logo

ABSI Absci Corp

$9.86
$0.115
(1.18%)
Today
EarningsNov 16
Mkt Cap$1.67B
Vol1.39M

About ABSI

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
66

Bullish Sentiment

How do you feel about ABSI?

Advertisement|Remove ads.